FDA Inspection 1234317 — Abiomed, Inc.

Abiomed, Inc. — FEI 1220648

The FDA completed an inspection of Abiomed, Inc. on Aug 5, 2025 in Danvers, MA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Aug 5, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Danvers, MA (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
419121 CFR 806.10(a)(1)Report of risk to health
45421 CFR 820.40(a)Document review, approval by designated individual
73121 CFR 803.50(a)(1)Report of Death or Serious Injury

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.